JPMorgan Chase to buy InstaMed

JPMorgan Chase & Co said May 17 that it agreed to buy InstaMed. Financial terms weren’t announced. The deal is valued at $550 million to $600 million, a source said. Instamed, of Philadelphia, is a healthcare payments company. FT Partners advised on the sale.

DealsNorth AmericaUSFinancial ServicesHealthcareBriefs